387 results
Page 3 of 20
8-K
EX-99.1
d754mu8
23 Aug 22
Windtree Therapeutics Announces KL4 Surfactant and AEROSURF® Global License Agreement
8:30am
8-K
EX-99.1
lvemj
11 Aug 22
Windtree Therapeutics Reports Second Quarter 2022 Financial Results and Provides Key Business Updates
4:06pm
DEFA14A
3o0kun3v1tr05n8du
3 Jun 22
Additional proxy soliciting materials
4:05pm
8-K
EX-99.1
bqth9vh6
23 May 22
The study met its primary endpoint of improved systolic blood pressure (SBP) profile at 6 hours
4:01pm
8-K
EX-99.1
45lydp u0
5 May 22
Windtree Therapeutics Reports First Quarter 2022 Financial Results and Provides Key Business Updates
4:04pm
8-K
EX-99.1
o1aqq h88s6n8vu
20 Apr 22
Windtree Announces Positive Topline Results from Its
7:07am
8-K
EX-99.1
btwhlmcvihb
31 Mar 22
Windtree Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Key Business Updates
7:05am
8-K
EX-99.1
2iyrp x6qm2
15 Mar 22
Windtree Completes Enrollment of Phase 2 Study of Istaroxime in Early Cardiogenic Shock
7:04am
8-K
EX-99.1
zxv9eejjyc
10 Nov 21
Windtree Therapeutics Reports Third Quarter 2021 Financial Results and Provides Key Business Updates
4:05pm
8-K
EX-99.1
f8tz3gezogyuq5 fin
5 Aug 21
Windtree Therapeutics Reports Second Quarter 2021 Financial Results and Provides Key Business Updates
5:31pm